We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
+$1.25B
(+3.9%)
Cap. Flow
-$1.82B
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
10.25%
Holding
1,526
New
88
Increased
442
Reduced
565
Closed
79
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mativ Holdings
MATV
|
+$106M |
| 2 |
Acacia Research
ACTG
|
+$101M |
| 3 |
Universal Corp
UVV
|
+$47.5M |
| 4 |
PARTNERRE LTD
PRE
|
+$41.9M |
| 5 |
Standard Motor Products
SMP
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOLXA
MOLEX INC CL-A
MOLXA
|
+$314M |
| 2 |
Nu Skin
NUS
|
+$241M |
| 3 |
Lincoln Electric
LECO
|
+$116M |
| 4 |
HITK
HI-TECH PHARMACAL INC
HITK
|
+$64.5M |
| 5 |
Dorman Products
DORM
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.94% |
| 2 | Technology | 17.69% |
| 3 | Consumer Discretionary | 14.45% |
| 4 | Financials | 10.27% |
| 5 | Materials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CSC
1351
DELISTED
Computer Sciences
CSC
| $98K | ﹤0.01% |
4,509
| – | – |
2013 Q2
1 quarter
|
|
1352
DELISTED
DOLAN COMPANY COMMON STOCK
DM
| $98K | ﹤0.01% |
43,300
-30,000
| -41% | -$67.2K |
2013 Q2
1 quarter
|
|
1353
EXL Service
EXLS
$5.96B
| $97K | ﹤0.01% |
17,000
+14,000
| +467% | +$80.1K |
2013 Q2
1 quarter
|
|
1354
Murphy Oil
MUR
$5.94B
| $97K | ﹤0.01% |
+1,600
| New | +$94.3K |
2013 Q3
0 quarters
|
|
|
GGS
1355
DELISTED
GLOBAL GEOPHYSICAL SERVICES, INC COM STK
GGS
| $95K | ﹤0.01% |
35,000
| – | – |
2013 Q2
1 quarter
|
|
1356
Credit Acceptance
CACC
$5.65B
| $94K | ﹤0.01% |
848
| – | – |
2013 Q2
1 quarter
|
|
1357
Designer Brands
DBI
$314M
| $94K | ﹤0.01% |
+2,200
| New | +$88.9K |
2013 Q3
0 quarters
|
|
|
FCRE
1358
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
| $94K | ﹤0.01% |
+1,180
| New | +$93.4K |
2013 Q3
0 quarters
|
|
1359
Royal Gold
RGLD
$20B
| $92K | ﹤0.01% |
+1,900
| New | +$98.5K |
2013 Q3
0 quarters
|
|
|
EOPN
1360
DELISTED
E2OPEN INC COM STK (DE)
EOPN
| $92K | ﹤0.01% |
4,100
-3,600
| -47% | -$73.9K |
2013 Q2
1 quarter
|
|
1361
DHI Group
DHX
$210M
| $90K | ﹤0.01% |
10,600
+4,800
| +83% | +$42.3K |
2013 Q2
1 quarter
|
|
|
TREC
1362
DELISTED
Trecora Resources
TREC
| $90K | ﹤0.01% |
9,841
| – | – |
2013 Q2
1 quarter
|
|
1363
Perdoceo Education
PRDO
$2.09B
| $87K | ﹤0.01% |
31,600
| – | – |
2013 Q2
1 quarter
|
|
|
RIC
1364
DELISTED
Richmont Mines Inc.
RIC
| $87K | ﹤0.01% |
60,900
| – | – |
2013 Q2
1 quarter
|
|
|
MEAS
1365
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $87K | ﹤0.01% |
1,600
+400
| +33% | +$19.7K |
2013 Q2
1 quarter
|
|
|
XOOM
1366
DELISTED
XOOM CORP COM
XOOM
| $86K | ﹤0.01% |
2,700
| – | – |
2013 Q2
1 quarter
|
|
|
CBPO
1367
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $85K | ﹤0.01% |
2,900
| – | – |
2013 Q2
1 quarter
|
|
1368
Lincoln National
LNC
$7.65B
| $84K | ﹤0.01% |
2,000
-2,300
| -53% | -$97.1K |
2013 Q2
1 quarter
|
|
1369
Harte-Hanks
HHS
$32.4M
| $82K | ﹤0.01% |
929
-1,350
| -59% | -$124K |
2013 Q2
1 quarter
|
|
|
CYNO
1370
DELISTED
Cynosure, Inc. Class A
CYNO
| $82K | ﹤0.01% |
+3,600
| New | +$89.5K |
2013 Q3
0 quarters
|
|
1371
REX American Resources
REX
$1.38B
| $80K | ﹤0.01% |
15,600
-282,000
| -95% | -$1.57M |
2013 Q2
1 quarter
|
|
1372
Donegal Group Class A
DGICA
$690M
| $76K | ﹤0.01% |
+5,400
| New | +$75.6K |
2013 Q3
0 quarters
|
|
1373
DELISTED
Valspar
VAL
| $76K | ﹤0.01% |
1,200
| – | – |
2013 Q2
1 quarter
|
|
|
CDI
1374
DELISTED
CDI Corp.
CDI
| $75K | ﹤0.01% |
4,900
+2,300
| +88% | +$34.3K |
2013 Q2
1 quarter
|
|
1375
Hovnanian Enterprises
HOV
$589M
| $73K | ﹤0.01% |
560
+80
| +17% | +$10.7K |
2013 Q2
1 quarter
|
|
Similar funds
Royce & Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Royce & Associates held 1,526 positions worth $33.6B, up 3.9% from $32.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Royce & Associates withdrew a net $1.82B in Q3 2013, closing 79 positions and reducing 565 holdings. Its most notable exit was MAIDENFORM BRANDS, INC, an estimated $44.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Genesco worth $17.8M.
- Royce & Associates's largest Q3 2013 buy was Genesco: 272,129 shares worth $17.8M.
- Royce & Associates added most to Mativ Holdings in Q3 2013, an estimated $106M increase.
- Royce & Associates's biggest Q3 2013 reduction was MOLEX INC CL-A, cutting an estimated $314M.
- Royce & Associates fully exited MAIDENFORM BRANDS, INC in Q3 2013, selling an estimated $44.3M.
- Royce & Associates's ten largest holdings make up 10% of its $33.6B portfolio in Q3 2013.
- Royce & Associates opened 88 new positions and closed 79 in Q3 2013.
- Royce & Associates's portfolio value rose 3.9% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q3 2013, filed 12 Nov 2013.